Rosuvastatin Dosage and Usage for Managing Elevated Cholesterol
Rosuvastatin should be initiated at 5-20 mg once daily for most patients with hypercholesterolemia, with dosage adjustments based on LDL-C reduction goals, cardiovascular risk factors, and patient characteristics. 1, 2
Initial Dosing Recommendations
Primary Prevention (without established ASCVD):
Secondary Prevention (with established ASCVD):
Administration Guidelines
- Take orally as a single dose at any time of day, with or without food 1
- Swallow tablets whole 1
- If a dose is missed, do not take an extra dose; resume with the next scheduled dose 1
- When taking with aluminum and magnesium hydroxide antacids, administer rosuvastatin at least 2 hours before the antacid 1
Special Population Considerations
Asian Patients
- Start with 5 mg once daily due to increased plasma concentrations 1
- Consider risks/benefits when treating Asian patients not adequately controlled at doses up to 20 mg 1
Renal Impairment
- Severe renal impairment (CLcr <30 mL/min/1.73 m²) not on hemodialysis:
- Start with 5 mg once daily
- Do not exceed 10 mg once daily 1
- No dosage adjustments needed for mild to moderate renal impairment 1
Elderly Patients
- For adults >75 years already on statin therapy, it's reasonable to continue treatment
- When initiating in this population, consider starting with moderate-intensity therapy 2
Drug Interactions and Dosage Modifications
- Cyclosporine: Do not exceed 5 mg once daily 1
- Gemfibrozil: Avoid concomitant use; if necessary, start at 5 mg and don't exceed 10 mg daily 1
- Antiviral medications (including sofosbuvir/velpatasvir/voxilaprevir, ledipasvir/sofosbuvir): Concomitant use not recommended 1
- Other antiviral medications (including atazanavir/ritonavir, lopinavir/ritonavir): Start at 5 mg and don't exceed 10 mg daily 1
Monitoring and Dose Adjustment
- Assess LDL-C as early as 4 weeks after initiating therapy 1
- Adjust dosage if necessary based on LDL-C response and treatment goals 1
- At daily doses of 5-40 mg, rosuvastatin produces mean reductions in LDL-C of 45-63% 4
Combination Therapy Considerations
- If LDL-C goals are not reached with rosuvastatin alone, consider adding ezetimibe 3
- The combination of rosuvastatin 5-10 mg with ezetimibe 10 mg produces greater improvements in lipid profile than up-titration of rosuvastatin alone 3
- Combination therapy may be particularly beneficial for high-risk patients, including those with diabetes 3
Clinical Efficacy
- Rosuvastatin demonstrates superior efficacy in lowering LDL-C compared to equivalent doses of atorvastatin, simvastatin, and pravastatin 4
- A starting dose of 10 mg typically reduces LDL-C by approximately 50% 5
- Rosuvastatin 5 mg produces mean LDL-C reductions ranging from 42-52% 6
- Long-term treatment with rosuvastatin 40 mg has been shown to be safe and effective in patients with severe hypercholesterolemia 7
Rosuvastatin is a potent statin that effectively reduces LDL-C levels and cardiovascular risk when dosed appropriately according to patient characteristics and risk factors.